PRGS Progress Software Corporation

Progress and Microsoft to Discuss .NET 5

Progress and Microsoft to Discuss .NET 5

Webinar series to focus on the state of .NET and the future of desktop app dev, and will help attendees start building new apps on.NET immediately after attending

BEDFORD, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- (NASDAQ: PRGS), the leading provider of products to develop, deploy and manage high-impact business applications, today announced that it will host two live webinars in November to help developers harness the power of the long-anticipated .NET 5 platform, expected to be released this month.

.NET 5 is expected to unify .NET Framework and .NET Core into one single .NET platform. Its transition from a Windows-only proprietary framework to a cross-platform, open source system will provide developers with powerful tools to build faster applications across web, desktop and mobile. Those who want to be ready for .NET 5 on the day of its release can join the two webinars hosted by Progress:

  • – Nov. 5, 2020 | 11 am ET

    Olia Gavrysh, program manager at Microsoft, and Sam Basu, senior developer advocate at Progress, will walk attendees through the latest trends in .NET desktop application development and will present insider tips and tricks on how to develop or migrate existing desktop applications to .NET 5.

  • – Nov. 19, 2020 | 11:00 am ET

    Progress senior developer advocates Ed Charbeneau and Sam Basu will discuss the new .NET 5 tooling and performance and will help developers acquire the knowledge and skills they need to successfully build apps for web, mobile and desktop on .NET.

Always in front with the newest .NET advancements, Progress was the first to deliver support for the latest preview of .NET 5. Earlier this year, the company announced that its leading development tools, , , , and ship with support for .NET 5.

To register for the two webinars, go to .

Additional Resources

  • Follow Progress on , and
  • Read the Progress

About Progress

(NASDAQ: PRGS) provides the leading products to develop, deploy and manage high-impact business applications. Our comprehensive product stack is designed to make technology teams more productive and we have a deep commitment to the open source community. With Progress, organizations can accelerate the creation and delivery of strategic business applications, automate the process by which apps are configured, deployed and scaled, and make critical data and content more accessible and secure—leading to competitive differentiation and business success. Over 1,700 independent software vendors, 100,000+ enterprise customers, and a three-million-strong developer community rely on Progress to power their applications. Learn about Progress at or .

Progress, JustMock, and Telerik are trademarks or registered trademarks of Progress Software Corporation and/or one of its subsidiaries or affiliates in the US and other countries. Any other trademarks contained herein are the property of their respective owners.

Press Contacts:           

Kim Baker           

Progress        

          

EN
05/11/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Progress Software Corporation

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: August 2, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: July 26, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: July 24, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Progress Software Announces Amended Credit Facility

Progress Software Announces Amended Credit Facility New $1.5B facility will support continued growth and provide greater scale and flexibility BURLINGTON, Mass., July 22, 2025 (GLOBE NEWSWIRE) --   (Nasdaq: PRGS), the trusted provider of AI-powered digital experience and infrastructure software, today announced that it has entered into a Fifth Amended and Restated Credit Agreement (the “Amended Credit Agreement”), which, among other things, increased the company’s revolving credit facility from $900 million to $1.5 billion and extended the maturity date to July 31, 2030. The Amended Cred...

Wedbush Research
  • Wedbush Research
UBI UBISOFT ENTERTAINMENT SA
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
TSLA TESLA INC
RARE ULTRAGENYX PHARMACEUTICAL INC.
PRGS PROGRESS SOFTWARE CORPORATION
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NBIX NEUROCRINE BIOSCIENCES INC.
KURA KURA ONCOLOGY INC.
GOOGL ALPHABET INC. CLASS A
GME GAMESTOP CORP. CLASS A
GERN GERON CORP.
FB FACEBOOK INC. CLASS A
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
FRX_CN FENNEC PHARMACEUTICALS
7974 NINTENDO CO. LTD.
EA ELECTRONIC ARTS INC.
PTGX PROTAGONIST THERAPEUTICS
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
ISR ISORAY
AMZN AMAZON.COM INC.
MSFT MICROSOFT CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
IDYA IDEAYA BIOSCIENCES
PASG PASSAGE BIO
BDTX BLACK DIAMOND THERAPEUTICS
ACET ADICET BIO INC
KROS KEROS THERAPEUTICS
ITOS ITEOS THERAPEUTICS
ZNTL ZENTALIS PHARMACEUTICALS
LRMR LARIMAR THERAPEUTICS INC
PRAX PRAXIS PRECISION MEDICINES
U UNITY SOFTWARE
TVTX TRAVERE THERAPEUTICS INC
VRDN VIRIDIAN THERAPEUTICS INC
PLTK PLAYTIKA HOLDING
BUR BURFORD CAPITAL
RBLX ROBLOX
DAWN DAY ONE BIOPHARMACEUTICALS INC
ELEV ELEVATION ONCOLOGY
APP APPLOVIN CORP
ATXS ASTRIA THERAPEUTICS INC
GMTX GEMINI THERAPEUTICS INC
VIGL VIGIL NEUROSCIENCE INC
TYRA TYRA BIOSCIENCES INC
EWTX EDGEWISE THERAPEUTICS INC
DDI DOUBLEDOWN INTERACTIVE CO LTD
APGE APOGEE THERAPEUTICS INC
SKLZ SKILLZ INC

ResearchPool Subscriptions

Get the most out of your insights

Get in touch